XML 47 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Related Party Balances and Transactions
 12 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
Related Party Balances and Transactions Related Party Balances and Transactions
McKesson Europe has investments in pharmacies located across Europe that are accounted for under the equity method. McKesson Europe maintains distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million, $178 million, and $141 million are included in the Consolidated Statements of Operations for the years ended March 31, 2022, 2021, and 2020, respectively, and receivables related to these transactions included in the Consolidated Balance Sheets were not material as of March 31, 2022 and 2021. Predominately all of these pharmacies were divested from the Company in the fourth quarter of 2022 as part of the completed sale of the Company’s Austrian business, while certain other remaining pharmacies are included in the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, “Held for Sale,” for additional information.
In 2022, 2021, and 2020, the Company’s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million, $111 million, and $60 million, respectively. Trade receivables related to these transactions from this investee were not material as of March 31, 2022 and 2021. During 2022, the Company’s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.
Refer to Financial Note 4, “Business Acquisitions and Divestitures,” for information regarding related party balances and transactions with Change and the Change Healthcare JV.